Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email mava@mava.org.
 

 

Check back regularly for news, coverage, and announcements about MAVA.

  

CIT Invests $100,000 in Lewis and Clark Pharmaceuticals

11/19/2012
The Herndon-based Center for Innovative Technology (CIT) said on Monday it has invested $100,000 in Charlottesville-based Lewis and Clark Pharmaceuticals, which focuses on adenosine-based compounds. The investment came from CIT's GAP Funds, which make seed-stage equity investments in Virginia-based technology, clean tech and life sciences companies. Lewis and Clark said it plans to initially focus its efforts on the markets for stress imaging and autoimmune diseases.

Read More